sridhar g s's Insider Trades & SAST Disclosures
sridhar g s's most recent trade in Glenmark Pharmaceuticals Ltd. was a Disposal of 559 Equity Shares done at an average price of Rs. 535.7 . Disclosure was reported to the exchange on Nov. 17, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for sridhar g s in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharma | SRIDHAR GORTHI | Director | Disposal | 17 Nov 2021 | 559 | 0 (0%) | 0.00% | 535.7 | 299,447 | 15 Nov 2021 15 Nov 2021 |
Insider Trading | Equity Shares | Market Sale |
| Dr. Reddy's Labs | G Malathi Sridhar | Designated Person | Disposal | 22 Dec 2020 | 284 | 500 (0%) | 0.00% | 5241 | 1,488,444 | 18 Dec 2020 18 Dec 2020 |
Insider Trading | Equity Shares | Market Sale |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.